ANIP (ANI Pharmaceuticals, Inc.) Rega marang bathi mangsa ngarep
ANI Pharmaceuticals' bet on skilled technologists and FDA standards ensures high production efficiency. The company's forward P/E ratio visualizes market expectations, where 6.90 reflects the metric's baseline level. Environmental responsibility is manifested in the safe disposal of chemicals, while the brand's pragmatic image is confirmed by supply reliability and the successful revival of niche generics.
Ringkesan rincian data analitis ANI Pharmaceuticals Corp (ANIP)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal ANI Pharmaceuticals|ANIP - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas ANI Pharmaceuticals|ANIP - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku ANI Pharmaceuticals Inc|ANIP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ANI Pharmaceuticals|Rasio cepet anipharmaceuticals.com
- rincian asil keuangan lan kelipatan valuasi:
ANIP - Asil keuangan resik|Bathi mangsa ngarep ANI Pharmaceuticals|ANIP - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep ANI Pharma|ANIP - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA ANI Pharmaceuticals Inc|ANIP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ANI Pharmaceuticals|ANIP - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan anipharmaceuticals.com|ANIP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ANI Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
Pambiji fundamental:ANI Pharmaceuticals, Inc.
To objectively assess asset quality, it is essential for an investor to compare current market value with projected earnings, which determines the extent to which a business is overvalued or undervalued. By analyzing the expected P/E multiple of ANI Pharmaceuticals (ANIP), you measure the value of future cash flows, which confirms the stability of the company's capitalization driven by consistent demand for its portfolio of niche generics.
Analisis perusahaan pesaing
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep MannKind Corporation (MNKD)|AMPH (amphastar.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PCRX (Pacira BioSciences, Inc.)|Pangali Forward P/E ARS Pharmaceuticals Inc SPRY|TBPH - Rega marang bathi mangsa ngarep|AQST (Aquestive Corp) - Rasio rega marang bathi mangsa ngarep|SCPH: Pangali Forward P/E|TECX - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TNXP|SXTC: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Eupraxia Pharmaceuticals (EPRX)|BHST: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E EXOZ (eXoZymes Inc)|Pangali mangsa ngarep rega marang bathi ORMP|Entera Bio Corp - Pangali Forward P/E|HYFT - Pangali Forward P/E|ABVC BioPharma Inc (ABVC) - Rega marang bathi mangsa ngarep|Cumberland Corp - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Quantum BioPharma Ltd|Prakiraan rega marang bathi fibrogen.com (FGEN)|Pangali Forward P/E TELO|Pangali Forward P/E ranitherapeutics.com (RANI)|Pangali Forward P/E SNYR (Synergy CHC)|RLYB - Prakiraan rega marang bathi|Lexaria - Pangali Forward P/E|Rasio prakiraan rega marang bathi pulmatrix.com|PTHL (ftzy.com.cn) - Prakiraan rega marang bathi|Aptorum Group (APM) - Pangali Forward P/E|Prakiraan rega marang bathi LYRA|IBO (Impact BioMedical, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E TNFA|Kapitalisasi marang proyeksi bathi cbdmd.com|Pangali Forward P/E PRFX (PainReform)|CYTO - Prakiraan rega marang bathi|Lipella - Pangali Forward P/E|OPTN - Pangali Forward P/E|Pieris Pharmaceuticals (PIRS) - Rega marang bathi mangsa ngarep|PROC (procapsgroup.com) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Qilian International Holding Group (QLI) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SLRN|Pangali Forward P/E TFF Pharmaceuticals, Inc (TFFP)
